Panbela provides business update and reports q4 and fy 2024 financial results

Minneapolis, march 26, 2024 (globe newswire) -- panbela therapeutics, inc. (nasdaq:pbla), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the quarter and full year ended december 31, 2023. as previously announced, management is hosting earnings call today at 4:30 p.m. et.
PBLA Ratings Summary
PBLA Quant Ranking